Loading…
← CockpitCompetitor Analysis › 300869.SZ Contec Medical Systems Co. Ltd. Class AOpen in the cockpit ↗

Contec Medical Systems Co. Ltd. Class A300869.SZCompetitor analysis, valuation and peers

China · CNY·Health Care›Medical Specialties
Momentum neutral 40
Mkt cap
$547M
US dollars, full cap
Free float
75%
of shares outstanding
$/day
$5.52M
20-day average traded
Fwd P/E
n/m
no positive forecast
ROIC−WACC
-13.3 pp
WACC 6.8%
Hurdle
+35 pp
Req g minus delivered
Close · CNYCN¥9.15
1D-1.1%
1W-8.0%
1M-11.8%
3M-21.0%
6M-25.9%
YTD-39.0%
1Y-44.2%
ATR %3.2%
52w lowhigh49.5% off high

What Contec Medical Systems does

Employees: 1,712

Contec Medical Systems at a glance

Size Contec Medical Systems (300869.SZ) is a China Health Care company (Medical Specialties) with a market value of $547M, the 3475th largest of 4,790 China companies the cockpit tracks. Shares closed at CN¥9.15 on 18 Nov 2026.

Performance Over six months the shares fell 25.9%, against -13.7% for the median peer and -20.0% for the China market (cap-weighted) — 7th lowest of 19 in its peer set.

Growth Revenue fell 2.5% over the last twelve months (peer median +8.7%); the operating margin is -16.1% (peer median 2.2%).

Valuation It trades at 5.5× enterprise value to sales against a peer median of 4.6× (8th most expensive of 19).

Price implies For today's price to make sense, revenue must grow about 15% a year for seven years (Req g). Recent delivered growth is -20%, so the hurdle is +35 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.

Capital Return on invested capital runs 13.3 points below its cost of capital (6.8% WACC).

Relative performance

809010021 May 202621 Aug 202618 Nov 2026Peer median 87300869.SZ 75
Six months, rebased to 100: Contec Medical Systems against the median of its 20 peers (local-currency closes).

Contec Medical Systems financials

Reported figures in CNY; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueCN¥478MCN¥464MCN¥476MCN¥737MCN¥706M
Revenue growth—-2%-36%+5%—
Gross profitCN¥212MCN¥210MCN¥222MCN¥408MCN¥321M
EBITDAn/a-CN¥26.0M-CN¥89.5MCN¥137MCN¥123M
Net income-CN¥91.1M-CN¥24.4M-CN¥77.9MCN¥166MCN¥196M
Free cash flowCN¥71.1MCN¥25.1MCN¥126MCN¥258MCN¥44.3M
Capital expenditureCN¥23.5MCN¥49.5MCN¥54.5MCN¥30.7MCN¥81.4M
Total debtCN¥810MCN¥967MCN¥787MCN¥1.05BCN¥1.58B

Quarterly statements and history in the cockpit →

Contec Medical Systems competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-100%0%+100%+200%+300%0%+50%605369603122ZJYLMYGN301235RCELPACB300952300439NNNN300639OBIO300314TCMD300869.SZ6-month return →1-month return →
Up and to the right = strong over both horizons. Contec Medical Systems is the large dot.

Fundamentals: revenue growth against valuation

0%+250%+500%+750%+1,000%0×50×100×605369603122ZJYLMYGNOBIOAVRVVVV300869.SZRevenue growth (TTM) →EV / Sales →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Contec Medical Systems is the large dot.

Capital: growth delivered against growth the price implies

-20%0%+20%-20%0%20%605369300439300639688075688581TCMD300869.SZGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Contec Medical Systems is the large dot.

Contec Medical Systems competitors and peer comparison

How Contec Medical Systems compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Contec Medical Systems against its 20 peers (data as of 18 Nov 2026)
Measure300869.SZPeer medianRank in peer set
1-month return-11.8%-4.3%5th lowest of 19
6-month return-25.9%-13.7%7th lowest of 19
Distance from 52-week high-49.5%-34.3%6th lowest of 20
Revenue growth (TTM)-2.5%+8.7%7th lowest of 20
Operating margin-16.1%2.2%6th lowest of 20
EV / Sales5.5×4.6×8th most expensive of 19
Growth the price implies (Req g, 7 yrs)15.0%7.2%2nd most demanding of 7
Growth delivered (Del g)-19.8%-0.6%lowest of 7
Hurdle (Req g minus delivered)+34.8 pp+8.7 pp2nd most demanding of 7
ROIC minus cost of capital-13.3 pp-1.3 pp5th lowest of 16

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginEV / SalesReq gDelivered g
Contec Medical Systems 300869.SZChina$547M-26%-2%-16%5.5×15.0%-19.8%
Zhejiang Gongdong Medical Technology 605369.SSChina$542M-21%+6%9%2.6×10.2%+6.5%
Cowealth Medical China 603122.SSChina$562M-34%-18%-5%5.9×n/an/a
Jin Medical International ZJYLUnited States$532M+47%-14%2%26.5×n/an/a
Myriad Genetics MYGNUnited States$530M+45%-3%-13%0.8×n/an/a
Wuhan Huakang Century Clean Technology 301235.SZChina$563M-57%+28%7%1.6×n/an/a
AVITA Medical RCELUnited States$529M+290%+17%-34%6.7×n/an/a
Pacific Biosciences of California PACBUnited States$573M+54%+4%-98%6.7×n/an/a
Jiangsu Hanvo Safety Product 300952.SZChina$575M-38%+6%8%3.3×n/an/a
MedicalSystem Biotechnology 300439.SZChina$518M-9%+14%2%1.5×6.0%-7.7%
Anbio Biotechnology NNNNUnited States$518M-89%+10%67%n/an/an/a
Guangdong Hybribio Biotech 300639.SZChina$511M-18%-7%4%3.9×0.4%-13.2%
Shofu 7979.TJapan$510M+32%+9%14%1.6×n/an/a
Orchestra BioMed OBIOUnited States$587M+87%+1,007%-195%18.3×n/an/a
Anteris Technologies Global AVRUnited States$508M-40%+9%-4,880%125.0×n/an/a
Assure Tech (Hangzhou) 688075.SSChina$508M-27%-9%-8%5.4×30.8%-18.6%
Ningbo David Medical Device 300314.SZChina$589M+25%+19%11%5.4×n/an/a
Hangzhou AGS MedTech 688581.SSChina$590M-22%-18%33%3.7×0.4%+27.8%
Tactile Systems Technology TCMDUnited States$592M+6%+14%9%1.5×8.4%+12.0%
vVARDIS VVVVUnited States$594Mn/a+148%-72%14.3×n/an/a
Sahajanand Medical Technologies SMT.NSIndia$595Mn/an/an/an/an/an/a

Questions

Which companies are Contec Medical Systems's closest peers?
The cockpit's peer set: Zhejiang Gongdong Medical Technology (605369.SS), Cowealth Medical China (603122.SS), Jin Medical International (ZJYL), Myriad Genetics (MYGN), Wuhan Huakang Century Clean Technology (301235.SZ), AVITA Medical (RCEL), Pacific Biosciences of California (PACB), Jiangsu Hanvo Safety Product (300952.SZ).
Is Contec Medical Systems expensive compared with its peers?
On ev / sales it trades at 5.5× against a peer median of 4.6×, 8th most expensive of 19 in its peer set. For today's price to make sense, revenue must grow about 15% a year for seven years (Req g). Recent delivered growth is -20%, so the hurdle is +35 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
How has Contec Medical Systems stock performed?
Over six months to 18 Nov 2026 the shares returned -25.9% against -13.7% for the median peer; over one year -44.2%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.